Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1472
https://www.valueinhealthjournal.com/article/S1098-3015(13)01543-X/fulltext
Title :
Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01543-X&doi=10.1016/j.jval.2013.03.1472
First page :
A284
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1043